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Analytical data of 5: R f 0.14 (Hex/ H, 5.27; S, 8.82; found: C, 46.03; H, 5.30; S 8.66 .
Methyl (2-iodoethyl 2,3,4-tri-O-acetyl-1-thio-β-D-glucopyranosid)uronate (6). Bromide 4
(3.38 g, 7.39 mmol, 1.00 equiv) was dissolved in a 15% NaI solution (5.54 g, 36.9 mmol, C NMR (CDCl 3 ) δ 2.9 (t, ICH 2 ), 20. 4, 20.5, 20.6 (3q, 3COCH 3 H, 4.20; S, 6.36; found: C, 35.64; H, 4.13; S, 6 .23.
S6 (3β,18β,20β)-3-{2-[Methyl (2,3,4-tri-O-acetyl-1-thio-β-D-glucopyranosyl)uronate] ethylamino}-11-oxo-olean-12-en-29-oic acid diphenylmethyl ester (8).
A solution of iodide 6 (3.50 g, 6 .94 mmol, 2.00 equiv) in DMF (11 mL) was purged with Ar for 15 min at rt. Amine 7 (2.20 g, 3. 47 mmol, 1.0 equiv) and DIPEA (2.25 g, 17.35 mmol, 5 .0 equiv) were added and the reaction mixture was stirred overnight at 45-50 °C external oil-bath temperature. HPLC analysis after 16 h indicated ~97% conversion of the starting material and the reaction mixture was allowed to reach rt. 5, 17.5, 17.7, 18.6, 18.8, 20.45, 20.50, 20.59, 20.63, 20.72, 22.0 (q, NCOCH 3 ), 23.1 (q, NCOCH 3 ), 23.27, 23.33, 23.9, 26.3, 26.4, 28.2, 28.3, 28.5, 28.7, 29.0, 30.3, 31.1, 31.7, 32.6, 37.0, 37.2, 37.4, 40.4, 40.79, 40.84, 41.0, 41.08, 41.16, 43.15, 43.18, 44.0, 45.2, 45.3, 45.5, 47.3, 47.97 (d, C18) added dropwise, and the reaction mixture was allowed to come to rt and was stirred while being monitored by HPLC (CHCl 3 /MeOH 9:1 + 0.5% AcOH). After 3 h all of the starting material was consumed. The solution was made neutral by the addition of satd. aq. NaHCO 3 (50 mL) at 0 °C (pH ~8). The phases were separated, the aqueous layer was extracted with DCM (4 x). The combined organic layers were washed with NaHCO 3 , water and brine, dried (Na 2 SO 4 ) and concentrated. The crude material was submitted to column chromatography (SiO 2 : 20 g, 1, 17.3, 18.2, 18.4, 21.2, 22.5, 22.9, 23.0 (4×q, 2×NCOCH 3 , 2×C27), 23.5, 26.0, 28.0, 28.1, 28.2, 28.4, 30.1, 30.6, 31.5, 32.2, 36.8, 36.9, 37.3, 40.0, 40.3, 40.5, 40.8, 43.0, 43.4, 45.1, 45.2, 45.6 (t, NCH 2 19, 17.2, 18.7, 18.8, 19.2, 19.5, 19.6, 22.1 (q, NCOCH 3 ), 23.1 (q, NCOCH 3 ), 23.8 (q, C27), 23.9, 24.4, 24.8, 27.4, 27.6, 28.8, 29.0, 29.2, 29.8 (t, SCH 2 ), 31.3 (t, SCH 2 ), 32.0, 33.0, 33.6, 33.7, 38.4, 38.5, 39.0, 41.5, 41.7, 41.9, 42.2, 42.4, 44.6, 44.9, 46.65, 46.69, 47.5 (t, NCH 2 1.09 (m, 12H, H1b, H5, H16b, H23, H24, H28), 37H, H2a, H2b, H6a, H6b, H7a, H7b, H15a, H15b, H16a, 18H, H19a, H19b, H21a, H21b, H22a, H22b, H25, H26, H27, H30, 3×OAc 4, 17.45, 17.7, 18.5, 18.8, 20.3 (q, COCH 3 ), 20.4 (q, COCH 3 ), 20.5 (q, COCH 3 ), 20.6 (q, COCH 3 ), 23.2, 23.3, 23.8, 26.3, 28.34, 28.4, 28.9, 29.2, 29.45, 31.0, 31.8, 32.5, 37, 37.2, 37.7, 40.3, 40.6, 40.8, 41.0 (t, C1), 43.2, 43.6, 45.3, 45.4, 45.7 (t, NCH 2 20, 16.24, 17.3, 17.5, 18.37, 18.40, 18.6, 23.0, 23.1, 23.6, 26.2, 26.3, 28.2, 28.3, 28.4, 29.1, 29.3, 29.9, 30.9, 31.7, 32.4, 36.9, 37.1, 37.5, 40.2, 40.5, 40.7, 40.9, 41.0, 43.2, 43.6, 45.2, 45.3, 45.9 (t, NCH 2 1, 17.2, 18.7, 18.8, 19.2, 19.5, 19.7, 23.7, 23.8, 24.4, 24.8, 27.6, 29.0, 29.3, 29.36, 29.43, 29.6, 31.5, 31.7, 32.4, 33.0, 33.1, 33.7, 33.8, 34.7, 38.4, 38.5, 39.6, 41.5, 41.95, 42.00, 43.9, 44.6, 44.7, 46.4, 46.7, 46.9 (t, NCH 2 value by using a 4-parameter logistic equation whereby the top of the curve was defined by the response (RLU) of untreated uninfected cells.
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